These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35053435)

  • 1. Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma.
    Comito F; Pagani R; Grilli G; Sperandi F; Ardizzoni A; Melotti B
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Strategies in Systemic Therapy for the Treatment of Melanoma.
    Ascierto PA; Flaherty K; Goff S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():751-758. PubMed ID: 30231371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy.
    Trojaniello C; Luke JJ; Ascierto PA
    Front Oncol; 2021; 11():670726. PubMed ID: 34178657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?
    Ziogas DC; Theocharopoulos C; Koutouratsas T; Haanen J; Gogas H
    Cancer Treat Rev; 2023 Feb; 113():102499. PubMed ID: 36542945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Clinical Trial Data Summation for BRAF-MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma.
    Luke JJ
    Oncologist; 2019 Nov; 24(11):e1197-e1211. PubMed ID: 31064886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Options for Advanced Melanoma After Anti-PD-1 Therapy.
    Babacan NA; Eroglu Z
    Curr Oncol Rep; 2020 Mar; 22(4):38. PubMed ID: 32198651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapy and Immunotherapy for Melanoma in Japan.
    Namikawa K; Yamazaki N
    Curr Treat Options Oncol; 2019 Jan; 20(1):7. PubMed ID: 30675668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists.
    Kakavand H; Wilmott JS; Long GV; Scolyer RA
    Pathology; 2016 Feb; 48(2):194-202. PubMed ID: 27020392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of advanced melanoma: a review of systemic and local therapies in combination with immune checkpoint inhibitors in phase 1 and 2 clinical trials.
    DePalo DK; Tarhini A; Zager JS
    Expert Opin Investig Drugs; 2022 Jan; 31(1):95-104. PubMed ID: 34996314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment.
    Masaoutis C; Kokkali S; Theocharis S
    Expert Opin Investig Drugs; 2021 May; 30(5):555-569. PubMed ID: 33650931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Targets for the Treatment of Melanoma.
    Ambrosi L; Khan S; Carvajal RD; Yang J
    Curr Oncol Rep; 2019 Nov; 21(11):97. PubMed ID: 31696329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Research in Melanoma and Aggressive Nonmelanoma Skin Cancer.
    Wilken R; Criscito M; Pavlick AC; Stevenson ML; Carucci JA
    Facial Plast Surg; 2020 Apr; 36(2):200-210. PubMed ID: 32413929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future roles of targeted therapy and immunotherapy in advanced melanoma.
    Olszanski AJ
    J Manag Care Spec Pharm; 2014 Apr; 20(4):346-56. PubMed ID: 24684639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in molecular targeted therapy for unresectable and metastatic BRAF-mutated melanoma.
    Kiniwa Y; Okuyama R
    Jpn J Clin Oncol; 2021 Mar; 51(3):315-320. PubMed ID: 33338202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition.
    Kreidieh FY; Tawbi HA
    Ther Adv Med Oncol; 2023; 15():17588359231186027. PubMed ID: 37484526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging systemic therapies for cutaneous metastatic melanoma.
    Mason R; Au L; Ingles Garces A; Larkin J
    Expert Opin Pharmacother; 2019 Jun; 20(9):1135-1152. PubMed ID: 31025594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma.
    Lelliott EJ; McArthur GA; Oliaro J; Sheppard KE
    Front Immunol; 2021; 12():661737. PubMed ID: 34025662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.